Every week, The American Journal of Managed Care\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care stories included another insurer announcing it would pass on drug rebates to consumers; FDA approved a new continuous glucose monitor and created a new medical device class; new guidelines address how to treat people with both HIV and cancer.\n\nRead more about the stories in this podcast:\nWhat We're Reading: Accidental Medicaid Enrollment; Cracking Down on Opioids; Passing on Drug Rebates: www.ajmc.com/newsroom/what-were-reading-accidental-medicaid-enrollment-cracking-down-on-opioids-passing-on-drug-rebatesUnitedHealthcare to Pass Drug Company Rebates Back to Consumers: www.ajmc.com/newsroom/unitedhealthcare-to-pass-drug-company-rebates-back-to-consumers\nOut-of-Pocket Costs for Insulin Are a Problem. Litigants in Case Disagree on Who Is at Fault: www.ajmc.com/newsroom/out-of-pocket-costs-for-insulin-are-a-problem-litigants-in-case-disagree-on-who-is-at-fault\nBrenda Schmidt Discusses Getting Ready for the Launch of Medicare DPP: www.ajmc.com/interviews/brenda-schmidt-discusses-getting-ready-for-the-launch-of-medicare-dpp\nFDA Approves Dexcom G6, Streamlines Review for Similar Interoperable CGMs: www.ajmc.com/newsroom/fda-approves-dexcom-g6-streamlines-review-for-similar-interoperable-cgms\nNCCN's New Guidelines Promote Better Cancer Care for People With HIV: www.ajmc.com/conferences/nccn-2018/nccns-new-guidelines-promote-better-cancer-care-for-people-with-hiv\nInstitute for Value-Based Medicine\u2014Advancing Quality in Oncology Care: www.ajmc.com/ivbm-registration